The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during the annual meeting and exhibit of the Radiological Society of North America in Chicago.
Completely redesigned, the system features a new 128-element system to that delivers high-resolution images across the entire body with faster imaging times, which means quick and accurate diagnosis. Patient comfort is enhanced, the company says, with the system’s new integrated coil concept that allows clinicians to perform multiple exams without repositioning the patient — an added benefit is more efficient workflow and technologist productivity.
Vantage Atlas’ optional 205-cm acquisition range allows for feet-first imaging for the entire body, except the neck and head. It offers a wide range of optional packages for cardiac imaging, including advanced echo planar imaging, diffusion and perfusion imaging, peripheral angiography and fresh blood imaging, SuperFASE (Fast Advanced Spin Echo) imaging and body vision. In addition, Toshiba’s SPEEDER parallel imaging allows for increased acquisition speed and reduced examination times.
Toshiba's patented Pianissimo technology reduces acoustic noise, the most significant cause of patient discomfort during an MRI exam, and enables clinicians to better utilize all of the system's high-field MRI capabilities.
March 30, 2026 
